Search

everythinglearnresearchcommunity

for

Search:↓

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

Lavender oil significantly promotes hair growth in mice.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

6-Gingerol, found in ginger, may slow down hair growth and could be used for hair removal.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

Minoxidil helps prevent hair loss from chemotherapy in rats.

The PS-b-PAA copolymer nanomicelles are effective for delivering a cancer treatment drug in photodynamic therapy.

The document concludes that "Dictamnus" has a rich cultural history and potential as a herbal medicine, warranting more research into its effects and safety.

Early hair whitening may indicate a higher risk of heart disease in young and middle-aged men.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Injecting a mix of human skin and hair cells into mice can grow new hair.

Using PGPR as biofertilizers can improve soil health and plant growth while reducing reliance on synthetic fertilizers.

Skin doctors should recognize and treat conditions like hair-pulling and skin-picking early, often using therapy and medication, to help 50-70% of patients.

New treatments for lupus show promise, but more research is needed, especially for children.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Finasteride helps treat hair loss by blocking enzyme activity.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.